Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fadima C Haidara

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Allergy and Clinical Immunology. Global|May 22, 2023
Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalenceJustin R Ortiz, Rachel S Laufer, Steven M Brunwasser, et al.
Vaccine|April 24, 2012
Efficacy of the oral pentavalent rotavirus vaccine in MaliSamba O Sow, Milagritos Tapia, Fadima C Haidara, et al.
Lancet (London, England)|March 14, 2025
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trialFatoumata Diallo, Fadima C Haidara, Milagritos D Tapia, et al.
The New England Journal of Medicine|June 2, 2021
Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian ToddlersMilagritos D Tapia, Samba O Sow, Abdi Naficy, et al.
The New England Journal of Medicine|June 4, 2025
Bedaquiline Activity against LeprosyAbdoulaye Fomba, Fadima C Haidara, Mamoudou Kodio, et al.
Vaccine|July 30, 2021
Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisionsRachel S Laufer, Amanda J Driscoll, Ranju Baral, et al.
Clinical and Vaccine Immunology : CVI|October 13, 2017
Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic ComparatorSamba O Sow, Milagritos D Tapia, Wilbur H Chen, et al.
The New England Journal of Medicine|May 24, 2023
Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and GambiaFadima C Haidara, Ama Umesi, Samba O Sow, et al.
Vaccine|May 13, 2025
Factors associated with laboratory-confirmed SARS-Cov-2 infection among patients with severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023Raphael O Anyango, Bryan O Nyawanda, Brian O Onyando, et al.
Vaccine|March 2, 2025
Factors associated with mortality among patients aged 12 years and above requiring hospitalization for severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023Brian O Onyando, Bryan O Nyawanda, Daniel Onguru, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology. Global|May 22, 2023
Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalenceJustin R Ortiz, Rachel S Laufer, Steven M Brunwasser, et al.
Vaccine|April 24, 2012
Efficacy of the oral pentavalent rotavirus vaccine in MaliSamba O Sow, Milagritos Tapia, Fadima C Haidara, et al.
Lancet (London, England)|March 14, 2025
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trialFatoumata Diallo, Fadima C Haidara, Milagritos D Tapia, et al.
The New England Journal of Medicine|June 2, 2021
Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian ToddlersMilagritos D Tapia, Samba O Sow, Abdi Naficy, et al.
The New England Journal of Medicine|June 4, 2025
Bedaquiline Activity against LeprosyAbdoulaye Fomba, Fadima C Haidara, Mamoudou Kodio, et al.
Vaccine|July 30, 2021
Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisionsRachel S Laufer, Amanda J Driscoll, Ranju Baral, et al.
Clinical and Vaccine Immunology : CVI|October 13, 2017
Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic ComparatorSamba O Sow, Milagritos D Tapia, Wilbur H Chen, et al.
The New England Journal of Medicine|May 24, 2023
Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and GambiaFadima C Haidara, Ama Umesi, Samba O Sow, et al.
Vaccine|May 13, 2025
Factors associated with laboratory-confirmed SARS-Cov-2 infection among patients with severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023Raphael O Anyango, Bryan O Nyawanda, Brian O Onyando, et al.
Vaccine|March 2, 2025
Factors associated with mortality among patients aged 12 years and above requiring hospitalization for severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023Brian O Onyando, Bryan O Nyawanda, Daniel Onguru, et al.
Pageof 3